13D Filing: Versant Venture Capital IV, L.P. and Crispr Therapeutics AG (CRSP)

Page 15 of 18

Page 15 of 18 – SEC Filing

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

September 15, 2017

 

 

 

Versant Venture Capital IV, L.P.

 

 

 

By: Versant Ventures IV, LLC

 

Its: General Partner

 

 

 

 

 

By:

/s/ Robin L. Praeger

 

 

Robin L. Praeger, Managing Director

 

 

 

Versant Side Fund IV, L.P.

 

 

 

By: Versant Ventures IV, LLC

 

Its: General Partner

 

 

 

By:

/s/ Robin L. Praeger

 

 

Robin L. Praeger, Managing Director

 

 

 

Versant Ventures IV, LLC

 

 

 

 

 

By:

/s/ Robin L. Praeger

 

 

Robin L. Praeger, Managing Director

 

 

 

 

 

Versant Venture Capital V, L.P.

 

 

 

By: Versant Ventures V, LLC

 

Its: General Partner

 

 

 

 

 

By:

/s/ Robin L. Praeger

 

 

Robin L. Praeger, Managing Director

 

 

 

Versant Affiliates Fund V, L.P.

 

 

 

By: Versant Ventures V, LLC

 

Its: General Partner

 

 

 

 

 

By:

/s/ Robin L. Praeger

 

 

Robin L. Praeger, Managing Director

 

 

 

 

 

Versant Ophthalmic Affiliates Fund I, L.P.

 

 

 

By: Versant Ventures V, LLC

 

Its: General Partner

 

 

 

 

 

By:

/s/ Robin L. Praeger

 

 

Robin L. Praeger, Managing Director

 

 

 

 

 

Versant Ventures V, LLC

 

 

 

 

 

By:

/s/ Robin L. Praeger

 

 

Robin L. Praeger, Managing Director

 

 

15


Follow Crispr Therapeutics Ag (NASDAQ:CRSP)

Page 15 of 18